ISIDORe : Integrated Services for Infectious Disease Outbreak Research

ISIDORe provides an integrated portfolio of cutting-edge research services and resources to study epidemic-prone pathogens

Free Access to high-containment facilities & resources through ISIDORe project

"Integrated Services for Infectious Disease Outbreak Research" ...

Risk group 4 pathogens call for proposals Pre-application deadline 07 April 2023, 23.59 CET

Get free of charge access to state-of-the-art facilities, cutting-edge services, for your research

European Research Infrastructure on Highly Pathogenic Agents

Access to leading European high containment (BSL4 laboratories) & complementary facilities

Our Services for COVID-19 research

Learn more on access opportunities to our BSL3 and complementary facilities

Follow our twitter: @ERINHA_RI

You can contact us here

Access to our intranet here

Download our portfolio here

ERINHA's concept

European distributed research infrastructure of Bio Safety Level 3 and 4 (BSL3 & BSL4) facilities providing access to perform large-scale research projects

Scientific strategy

From Discovery to Prevention: ERINHA’s Research Approach

Pathogens We Study

ERINHA focuses on high-consequence pathogens of Risk Group 4 with no available countermeasures and high transmission and mortality rates

Unique facilities and scientists

The cutting edge research performed at ERINHA is made possible by a range of highly specialised European bio-contained facilities and unique expertise

News & Events

1st CCHFV Africa Conference

Join ISIDORe first year anniversary webinar

Open applications: Development of an Access Management System for ISIDORe

All news

Twitter feeds

@ ·

now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter

"ERINHA was created by foresighted scientists who understood that infectious diseases will always be a major threat to humanity. They established this federation of high-containment facilities, forming a distributed European infrastructure. It is open to academic and industrial researchers globally, to facilitate the study of the most virulent pathogens, and to accelerate the development of much-needed diagnostics, therapeutics, and vaccines. The recurring outbreaks of Ebola virus disease, the spread of Crimean-Congo haemorrhagic fever virus, and the appearance of worrying new pathogens, show that these needs are ever-present. ERINHA, with its regional and global partners, will continue its mission to help ensure that Europe, and the world, is better prepared for future disease outbreaks."

Jonathan Ewbank, DG of ERINHA

Members

Our adress

ERINHA AISBL
98, rue du Trône / Boîte n°4
B-1050 Bruxelles

ERINHA AISBL CCU
101, rue Tolbiac – 75013 Paris

contact@erinha.eu

Extra links

Newsletters

Subscribe for latest articles and resources

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Toujours activé

Functional

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Type	Durée	Description
GPS	1	29 minutes	This cookie is set by Youtube and registers a unique ID for tracking users based on their geographical location